Drug Identification and Testing in the Juvenile Justice System PDF Download

Author: Ann H. Crowe
Publisher:
ISBN:
Category : Drug abuse and crime
Languages : en
Pages : 96

View

Book Description

Author: New Jersey. Office of the Attorney General
Publisher:
ISBN:
Category : Drugs and employment
Languages : en
Pages : 66

View

Book Description

Author: Richard O. Lempert
Publisher:
ISBN:
Category : Alcoholism and employment
Languages : en
Pages :

View

Book Description

Author: United States. Department of Justice
Publisher:
ISBN:
Category : Justice, Administration of
Languages : en
Pages : 720

View

Book Description

Author: Alain G. Verstraete
Publisher: Pharmaceutical Press
ISBN: 0853696942
Category : Business & Economics
Languages : en
Pages : 461

View

Book Description
This comprehensive text provides clear explanations of the effects of drugs on human performance and the need for workplace drug testing. It provides essential information on the regulatory and legal frameworks around the world, how to set policies and coverage of all aspects of drug analysis and the associated interpretation of results.Contents include:* epidemiology of drug use in the working population* the evidence base and guidelines for workplace drug testing* legal, regulatory aspects and policies for drugs and alcohol* urine and alternative sample collection process* analytical techniques and specimen adulteration.Case studies of successful programmes are also included to illustrate the principles discussed.Written by internationally acknowledged experts this informative book will be essential reading for anyone interested in workplace drug testing or setting up such a system including clinical and forensic toxicologists, occupational health physicians, nurses, human resources, drug counselling and treatment providers, analytical chemists and lawyers.Alain Verstraete is Professor at the Department of Clinical Chemistry, Microbiology and Immunology, Ghent University, Ghent, Belgium and Department Head of the Toxicology Laboratory of the Laboratory of Clinical Biology, Ghent University Hospital, Ghent, Belgium.

Author: Peter O. Rostenberg
Publisher:
ISBN:
Category : Hospital patients
Languages : en
Pages : 108

View

Book Description

Author: Steven W. Gust
Publisher:
ISBN:
Category : Drug abuse
Languages : en
Pages : 254

View

Book Description
Comprises 14 articles reporting on experimental research.

Author:
Publisher:
ISBN:
Category : Drug testing
Languages : en
Pages : 104

View

Book Description
These guidelines developed by the California Commission on Peace Officer Standards and Training (POST) are to be used by agencies to conduct the pre-employment drug screening that should be a component of their comprehensive substance abuse programs. The guidelines are designed to help law enforcement agencies implement legally defensible and cost-efficient programs. A brief discussion of legal issues concerning drug screening of prospective employees covers the relevant court decisions and Federal guidelines contained in the Americans with Disabilities Act. The section on technical issues discusses some of the important program considerations regarding specimen collection, analytical methodologies, substances to be tested, and laboratories. The section on procedural issues addresses the logistics of moving applicants through the drug screening process in a secure and efficient way and examines issues including collection site security, chain of custody, and personal privacy. National Institute on Drug Abuse specimen collection guidelines are outlined, current California law enforcement policies are described, and recommendations from the model testing policy of the International Association of Chiefs of Police are provided. Supporting documents are contained in the appendixes.

Author: Craig W. Stevens
Publisher: Academic Press
ISBN: 0128005823
Category : Medical
Languages : en
Pages : 260

View

Book Description
The Drug Expert: A Practical Guide to the Impact of Drug Use in Legal Proceedings targets academic and industry pharmacologists, pharmacology graduate students, and professionals and students of affiliated disciplines, such as pharmacy and toxicology. Users will find it to be an invaluable reference for those involved in the field. In addition, pharmacists and others who increasingly serve as expert witnesses and toxicologists will find an array of very useful information. - Focuses on important topics for the consulting pharmacologist, including prescription, over-the-counter and illegal drugs and their effects on criminal and civil proceedings - Details the "how-to aspects of being an expert witness in pharmacology by presenting real-life cases and effective tips and experiences - Includes several appendices, such as a sample letter of engagement and fee schedule, a litigation report, a consulting invoice and valuable resources

Author: National Academies of Sciences, Engineering, and Medicine
Publisher: National Academies Press
ISBN: 0309459575
Category : Medical
Languages : en
Pages : 483

View

Book Description
Drug overdose, driven largely by overdose related to the use of opioids, is now the leading cause of unintentional injury death in the United States. The ongoing opioid crisis lies at the intersection of two public health challenges: reducing the burden of suffering from pain and containing the rising toll of the harms that can arise from the use of opioid medications. Chronic pain and opioid use disorder both represent complex human conditions affecting millions of Americans and causing untold disability and loss of function. In the context of the growing opioid problem, the U.S. Food and Drug Administration (FDA) launched an Opioids Action Plan in early 2016. As part of this plan, the FDA asked the National Academies of Sciences, Engineering, and Medicine to convene a committee to update the state of the science on pain research, care, and education and to identify actions the FDA and others can take to respond to the opioid epidemic, with a particular focus on informing FDA's development of a formal method for incorporating individual and societal considerations into its risk-benefit framework for opioid approval and monitoring.